Skip to main content

Table 3 Distribution of fluoroquinolone-resistant Pseudomonas aeruginosa from healthy and infected dogs

From: Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs

Antimicrobial agentsMIC (μg/mL)No. (%) resistant strainsp-value
RangeBreakpointHealthy group (n = 38)Infected group (n = 46)
Nalidixic acid0.05–256≥3238 (100.0)46 (100.0)n/a
Ciprofloxacin0.015–32≥44 (10.5)7 (15.2)0.747
Levofloxacin0.015–32≥85 (13.2)7 (15.2)0.700
Enrofloxacin0.03–16≥46 (15.8)17 (35.4)0.031 a
Marbofloxacin0.03–16≥45 (13.2)12 (26.1)0.142
  1. a Statistically significant (p < 0.05)